Targeted Oncology8 小时
FDA Grants Breakthrough Therapy Designation to Darovasertib in Melanoma
A phase 3 trial plans to further assess neoadjuvant darovasertib for the potential treatment of patients with primary uveal ...
SunLive8 小时
Woman recovering after $550,000 brain surgery
A Rotorua woman who went to the US for brain surgery says the $550,000 operation went “as well as it could” with 95% of her ...
Rotorua woman Amelia Branson recovering after $550,000 brain surgery in United States
A Rotorua woman who went to the US for brain surgery says the $550,000 operation went “as well as it could” with 95% of her ...
Le Lézard17 小时
IDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation for Darovasertib ...
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that the U.S. Food and Drug Administration (FDA) ...